HSIC has been the topic of a number of other reports. Bank of America lifted their target price on Henry Schein from $69.00 to $71.00 and gave the stock a neutral rating in a research report on Tuesday, December 3rd. Barrington Research restated a buy rating and set a $75.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Piper Jaffray Companies boosted their price objective on Henry Schein from $72.00 to $80.00 and gave the company an overweight rating in a research report on Monday, November 11th. Zacks Investment Research lowered Henry Schein from a hold rating to a sell rating and set a $71.00 target price for the company. in a research note on Wednesday, November 6th. Finally, ValuEngine raised Henry Schein from a sell rating to a hold rating in a research report on Tuesday, December 3rd. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company. The company currently has an average rating of Hold and an average target price of $72.08.
NASDAQ HSIC traded down $0.29 during trading on Tuesday, hitting $68.53. The company’s stock had a trading volume of 29,920 shares, compared to its average volume of 904,809. The company has a quick ratio of 0.92, a current ratio of 1.63 and a debt-to-equity ratio of 0.30. The firm has a 50 day moving average price of $67.42 and a 200 day moving average price of $65.88. The firm has a market cap of $10.14 billion, a P/E ratio of 16.62, a price-to-earnings-growth ratio of 2.26 and a beta of 0.85. Henry Schein has a 52 week low of $56.58 and a 52 week high of $72.81.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.04. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.52 billion. Henry Schein had a return on equity of 15.93% and a net margin of 4.66%. Henry Schein’s revenue for the quarter was up 6.5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.03 earnings per share. On average, equities analysts expect that Henry Schein will post 3.45 earnings per share for the current year.
Henry Schein announced that its board has authorized a share buyback plan on Thursday, October 31st that allows the company to buyback $400.00 million in shares. This buyback authorization allows the company to repurchase up to 4.3% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.
In other news, CFO Steven Paladino sold 21,370 shares of the stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $68.83, for a total transaction of $1,470,897.10. Following the sale, the chief financial officer now directly owns 144,863 shares of the company’s stock, valued at $9,970,920.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman James P. Breslawski sold 6,856 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $66.96, for a total transaction of $459,077.76. Following the completion of the sale, the insider now directly owns 242,190 shares of the company’s stock, valued at approximately $16,217,042.40. The disclosure for this sale can be found here. Insiders have sold a total of 123,655 shares of company stock valued at $8,373,585 over the last ninety days. Insiders own 1.06% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. AGF Investments Inc. lifted its position in Henry Schein by 6.2% during the 2nd quarter. AGF Investments Inc. now owns 2,816 shares of the company’s stock worth $197,000 after buying an additional 164 shares in the last quarter. World Asset Management Inc boosted its position in Henry Schein by 1.7% during the third quarter. World Asset Management Inc now owns 10,850 shares of the company’s stock valued at $689,000 after purchasing an additional 178 shares during the last quarter. Rational Advisors LLC grew its stake in Henry Schein by 24.9% in the second quarter. Rational Advisors LLC now owns 903 shares of the company’s stock valued at $63,000 after purchasing an additional 180 shares in the last quarter. Advisor Group Inc. grew its stake in Henry Schein by 3.8% in the second quarter. Advisor Group Inc. now owns 5,569 shares of the company’s stock valued at $388,000 after purchasing an additional 204 shares in the last quarter. Finally, Enterprise Financial Services Corp grew its stake in Henry Schein by 101.3% in the third quarter. Enterprise Financial Services Corp now owns 483 shares of the company’s stock valued at $31,000 after purchasing an additional 243 shares in the last quarter.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: Economic Bubble
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.